热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
FITC anti-mouse TER-119/Erythroid Cells Antibody
产品名称：
FITC anti-mouse TER-119/Erythroid Cells Antibody
产品类别：
抗体
产品编号：
116205
产品应用：
116205
[价格]
规格 价格 库存
50µg ￥ 588 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References

(PubMed link indicates BioLegend citation)
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Suzuki M, et al. 2015. J Immunol. 195: 1273-1281. PubMed
  2. Katsumura KR, et al. 2018. Proc Natl Acad Sci U S A. 115:E10109. PubMed
  3. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  4. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  5. Lawson H, et al. 2021. Stem Cell Reports. 16:2784. PubMed
  6. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  7. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  8. Ju W, et al. 2020. J Biomed Sci. 27:91. PubMed
  9. Sch?nberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  10. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  11. Chen T, et al. 2021. JCI Insight. 6:. PubMed
  12. Tan X, et al. 2021. Front Oncol. 11:768222. PubMed
  13. Jin L, et al. 2016. Stem Cell Res. 16:40-53. PubMed
  14. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  15. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  16. Agarwal S, et al. 2015. Cell Rep. 13: 2147-2158. PubMed
  17. Greenblatt SM, et al. 2018. Cancer Cell. 33:1111. PubMed
  18. Jiang X, et al. 2021. Sci Signal. 14:. PubMed
  19. Krishack PA, et al. 2021. Am J Respir Cell Mol Biol. 64:569. PubMed
  20. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  21. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  22. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  23. Grandl G, et al. 2016. Mol Metab. 5:937-947. PubMed
  24. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  25. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  26. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  27. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  28. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  29. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  30. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  31. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  32. Guarnerio J, et al. 2015. Cancer Discovery. 5:396. PubMed
  33. Ku C, et al. 2015. Genes Dev. 29: 1930-1941. PubMed
  34. Crispin A, et al. 2020. J Clin Invest. 130:5245. PubMed
  35. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  36. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  37. de Barros SC, et al. 2020. J Immunol. 205:2423. PubMed
  38. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  39. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  40. Zhang W, et al. 2020. Nat Commun. 11:1187. PubMed
  41. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  42. Lu Y, et al. 2020. Immunity. 52:782. PubMed
  43. Dong X, et al. 2022. Front Immunol. 13:896472. PubMed
  44. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  45. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  46. Zhang Q, et al. 2022. Commun Biol. 5:544. PubMed
  47. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  48. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  49. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  50. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  51. Mesa-Nu?ez C, et al. 2022. Mol Ther Methods Clin Dev. 26:459. PubMed
  52. Kim DJ, et al. 2020. Proc Natl Acad Sci U S A. 117:15837. PubMed
  53. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  54. Zhang J, et al. 2019. Exp Hematol. 78:21:00. PubMed
  55. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  56. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  57. Wang X, et al. 2022. Elife. 11:. PubMed
  58. Koh BI, et al. 2020. Nat Commun. 3.143055556. PubMed
  59. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  60. Rivera CA, et al. 2022. Immunity. 55:129. PubMed
  61. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  62. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  63. Liang Z, et al. 2022. iScience. 25:105233. PubMed
  64. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
RRID
AB_313706 (BioLegend Cat. No. 116205) AB_313707 (BioLegend Cat. No. 116206)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID
UniProt
View information about TER-119 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线